InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,712.69
(
-0.28%
)
US TECH 100
19,519.20
(
0.41%
)
Dow Jones
41,794.60
(
-0.61%
)
Brent Oil
75.25
(
0.17%
)
Bitcoin
68,749.34
(
1.37%
)
Post# of 253527
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jb_118

Send PM Follow Ignore
Followers 0
Posts 253
Boards Moderated 0
Alias Born 03/01/2006

jb_118

Re: DewDiligence post# 221460

Friday, 10/18/2019 5:21:55 PM

Friday, October 18, 2019 5:21:55 PM

Post# of 253527
ARWR R&D Day slides (2019):

http://ir.arrowheadpharma.com/static-files/26bc6a27-874e-4524-87e2-2134b56d00e4


Link to webcast (3+ hours)
http://lifesci.rampard.com/20191018/reg.jsp

I haven't gone over the whole thing, but the HBV work isn't mentioned much in the slide deck. They will have late breakers on both APOC3 and ANG3 and AHA November 18th.

Amgen seems to have dropped one of their collaborations on an undisclosed CV target.




Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up